These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 32159258)

  • 1. Comparison of the effects of hemodialysis and hemodiafiltration on left ventricular hypertrophy in end-stage renal disease patients: A systematic review and meta-analysis.
    Hameed I; Gaudino M; Naik A; Rahouma M; Robinson NB; Ruan Y; Demetres M; Bossola M
    Semin Dial; 2020 Mar; 33(2):120-126. PubMed ID: 32159258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of hemodiafiltration and change in cardiovascular parameters.
    Mostovaya IM; Bots ML; van den Dorpel MA; Grooteman MP; Kamp O; Levesque R; Ter Wee PM; Nubé MJ; Blankestijn PJ
    Clin J Am Soc Nephrol; 2014 Mar; 9(3):520-6. PubMed ID: 24408114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high efficiency post-dilution on-line hemodiafiltration or conventional hemodialysis on residual renal function and left ventricular hypertrophy.
    Schiffl H; Lang SM; Fischer R
    Int Urol Nephrol; 2013 Oct; 45(5):1389-96. PubMed ID: 23225079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular protective effects of on-line hemodiafiltration: comparison with conventional hemodialysis.
    Ohtake T; Oka M; Ishioka K; Honda K; Mochida Y; Maesato K; Moriya H; Hidaka S; Kobayashi S
    Ther Apher Dial; 2012 Apr; 16(2):181-8. PubMed ID: 22458399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of frequent or extended hemodialysis on cardiovascular parameters: a meta-analysis.
    Susantitaphong P; Koulouridis I; Balk EM; Madias NE; Jaber BL
    Am J Kidney Dis; 2012 May; 59(5):689-99. PubMed ID: 22370022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levocarnitine Improves Cardiac Function in Hemodialysis Patients With Left Ventricular Hypertrophy: A Randomized Controlled Trial.
    Higuchi T; Abe M; Yamazaki T; Okawa E; Ando H; Hotta S; Oikawa O; Kikuchi F; Okada K; Soma M
    Am J Kidney Dis; 2016 Feb; 67(2):260-70. PubMed ID: 26508680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of on-line hemodiafiltration on improving the cardiovascular function parameters in children on regular dialysis.
    Fadel FI; Makar SH; Zekri H; Ahmed DH; Aon AH
    Saudi J Kidney Dis Transpl; 2015 Jan; 26(1):39-46. PubMed ID: 25579714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
    Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI
    Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation between hypervolemia, left ventricular hypertrophy and fibroblast growth factor 23 in hemodialysis patients.
    Unver S; Kavlak E; Gümüsel HK; Celikbilek F; Esertas K; Muftuoglu T; Kirilmaz A
    Ren Fail; 2015 Jul; 37(6):951-6. PubMed ID: 26030798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of left ventricular hypertrophy in Chinese hemodialysis patients is higher than that in peritoneal dialysis patients.
    Tian JP; Wang T; Wang H; Cheng LT; Tian XK; Lindholm B; Axelsson J; Du FH
    Ren Fail; 2008; 30(4):391-400. PubMed ID: 18569912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodiafiltration maintains a sustained improvement in blood pressure compared to conventional hemodialysis in children-the HDF, heart and height (3H) study.
    De Zan F; Smith C; Duzova A; Bayazit A; Stefanidis CJ; Askiti V; Azukaitis K; Canpolat N; Agbas A; Anarat A; Aoun B; Bakkaloglu SA; Borzych-Dużałka D; Bulut IK; Habbig S; Krid S; Licht C; Litwin M; Obrycki L; Paglialonga F; Ranchin B; Samaille C; Shenoy M; Sinha MD; Spasojevic B; Yilmaz A; Fischbach M; Schmitt CP; Schaefer F; Vidal E; Shroff R
    Pediatr Nephrol; 2021 Aug; 36(8):2393-2403. PubMed ID: 33629141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive Hemodialysis, Left Ventricular Hypertrophy, and Cardiovascular Disease.
    McCullough PA; Chan CT; Weinhandl ED; Burkart JM; Bakris GL
    Am J Kidney Dis; 2016 Nov; 68(5S1):S5-S14. PubMed ID: 27772643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between different blood pressure measurements and left ventricular mass by cardiac magnetic resonance imaging in end-stage renal disease.
    Merchant A; Wald R; Goldstein MB; Yuen D; Kirpalani A; Dacouris N; Ray JG; Kiaii M; Leipsic J; Kotha V; Deva D; Yan AT
    J Am Soc Hypertens; 2015 Apr; 9(4):275-84. PubMed ID: 25753299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Echocardiographic changes following hemodialysis initiation in patients with advanced chronic kidney disease and symptomatic heart failure with reduced ejection fraction.
    Ganda A; Weiner SD; Chudasama NL; Valeri AM; Jadoon A; Shimbo D; Radhakrishnan J
    Clin Nephrol; 2012 May; 77(5):366-75. PubMed ID: 22551882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of myocardial perfusion during hemodialysis and hemodiafiltration.
    De Andrade R; Kotze T; Lesosky M; Swanepoel C
    Nephron Clin Pract; 2014; 126(3):151-8. PubMed ID: 24776695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast growth factor 23 and left ventricular mass index in maintenance hemodialysis patients: standard versus long nocturnal hemodialysis.
    Knap B; Večerić-Haler Ž; Benedik M; Buturović-Ponikvar J; Ponikvar R; Bren AF
    Ther Apher Dial; 2013 Aug; 17(4):407-11. PubMed ID: 23931880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in left ventricular filling parameters before and after dialysis in patients with end stage renal disease.
    Ersbøll M; Raja AA; Warming PE; Nielsen TL; Plesner LL; Dalsgaard M; Schou M; Rydahl C; Brandi L; Iversen K
    Int J Cardiovasc Imaging; 2019 Sep; 35(9):1673-1681. PubMed ID: 31093896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of hemodiafiltration or hemofiltration compared with hemodialysis on mortality and cardiovascular disease in chronic kidney failure: a systematic review and meta-analysis of randomized trials.
    Wang AY; Ninomiya T; Al-Kahwa A; Perkovic V; Gallagher MP; Hawley C; Jardine MJ
    Am J Kidney Dis; 2014 Jun; 63(6):968-78. PubMed ID: 24685515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of short daily hemodialysis and extended standard hemodialysis on blood pressure and cardiac hypertrophy: a comparative study.
    Fagugli RM; Pasini P; Pasticci F; Ciao G; Cicconi B; Buoncristiani U
    J Nephrol; 2006; 19(1):77-83. PubMed ID: 16523430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of online hemodiafiltration compared with hemodialysis on quality of life in patients with ESRD: A systematic review and meta-analysis of randomized trials.
    Suwabe T; Barrera-Flores FJ; Rodriguez-Gutierrez R; Ubara Y; Takaichi K
    PLoS One; 2018; 13(10):e0205037. PubMed ID: 30335792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.